Advertisement

Topics

Investors saw opportunity to build ‘a leading mid-sized European CRO’

14:06 EDT 31 Aug 2017 | Outsourcing-Pharma

Two European drug discovery contract research organizations (CRO) have merged to form the Mercachem-Syncom Group.

Original Article: Investors saw opportunity to build ‘a leading mid-sized European CRO’

NEXT ARTICLE

More From BioPortfolio on "Investors saw opportunity to build ‘a leading mid-sized European CRO’"

Quick Search
Advertisement